| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 4,913,085 | 4,955,443 | 3,436,921 | | Cost of Revenue | 3,438,797 | 3,484,658 | 2,350,606 | | | Gross Profit | 1,474,288 | 1,470,785 | 1,086,315 | | | Operating Expenses | | Research Development |
-
| 10,166 | 6,157 | | Selling General and Administrative | 626,439 | 598,936 | 386,679 | | Non Recurring | (10,499) |
-
| (5,094) | | Others | 28,718 | 15,462 | 6,192 | | | | Total Operating Expenses |
-
|
-
| 393,935 | | | | Operating Income or Loss | 829,630 | 846,221 | 692,380 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (20,844) | 81,098 | 61,915 | | Earnings Before Interest And Taxes | 815,772 | 933,770 | 761,606 | | Interest Expense | 45,008 | 26,706 | 5,999 | | Income Before Tax | 770,765 | 907,064 | 755,608 | | Income Tax Expense | 104,645 | 97,212 | 85,620 | | Minority Interest | (1,911) | (602) |
-
| | | | Net Income From Continuing Ops | 664,210 | 809,249 | 669,988 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| 899 | | Other Items |
-
|
-
|
-
| | | | Net Income | 664,210 | 809,249 | 670,887 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $664,210 | $809,249 | $670,887 |
|
0.72% Nasdaq 
Income Statement
